Future prospect of nano-based drug delivery approaches against pancreatic cancer and expected pitfalls of the technology

Several scientific breakthroughs have undergone radical change as a result of the development of nanotechnology, but the introduction of nanomedicine stands out. Research has focused particularly on nano-drug administration for the treatment of cancer. Phytochemicals, or naturally occurring plant molecules, have been widely studied for their anticancer qualities. Due to its effectiveness in diagnosing and treating different malignancies, nanotechnology has recently attracted more interest. Nanocarriers have been used to get beyond the drawbacks of traditional anticancer drug delivery methods, such as their nonspecificity, adverse side effects, burst release, and harm to healthy cells, and improved by nanocarriers. Numerous nanocarriers were developed, but still, only a little has gotten clinical clearance for the transfer of anticancer drugs to the precise areas in which they will exert their desired effects. In the following chapter, conventional therapy for pancreatic cancer, the prospects of nanotechnology in pancreatic cancer treatment, the varied types of the drug delivery system, and challenges of nano-based drug delivery systems for pancreatic cancer therapy applications are discussed, which promises in terms of possible clinical translation.